GGrantIndex
Sort

78,016 grants matching breast cancer

Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy

$451,366
Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA

Glutamine synthetase in cancer cell metabolism and oncogenesis

$451,360
Wei-Xing Zong · Rutgers, The State Univ Of N.J. · R01 · FY2020 · CA

Glutamine synthetase in cancer cell metabolism and oncogenesis

$451,360
Wei-Xing Zong · Rutgers, The State Univ Of N.J. · R01 · FY2018 · CA

Glutamine synthetase in cancer cell metabolism and oncogenesis

$451,360
Wei-Xing Zong · Rutgers, The State Univ Of N.J. · R01 · FY2021 · CA

Statistical Methods For Genetic Epidemiology

$451,317
Clarice Weinberg · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES

Mindfulness Based Stress Reduction for Psycho-Immune Dysregulation in Cancer

$451,310
Herbert L Mathews · Loyola University Chicago · R01 · FY2011 · CA

Cyclin A Function in Stem Cells and in Neoplasia

$451,215
Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Cyclin A Function in Stem Cells and in Neoplasia

$451,215
Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2017 · CA

Cyclin A Function in Stem Cells and in Neoplasia

$451,215
Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2016 · CA

Cyclin A Function in Stem Cells and in Neoplasia

$451,215
Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2013 · CA

Therapeutic targeting of orphan NR in ER-negative breast cancer

$451,202
Hongwu Chen · University Of California At Davis · R01 · FY2021 · CA

Opposing Functions of BRD4 Isoforms in Breast Cancer

$451,084
Cheng-Ming Chiang · Ut Southwestern Medical Center · R01 · FY2023 · CA

Opposing Functions of BRD4 Isoforms in Breast Cancer

$451,083
Cheng-Ming Chiang · Ut Southwestern Medical Center · R01 · FY2022 · CA

Mechanism of Action of Estrogens and Antiestrogens

$451,071
Donald P McDonnell · Duke University · R37 · FY2009 · DK

Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer

$451,069
Marcus E Peter · Northwestern University At Chicago · R01 · FY2023 · CA

Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy

$450,986
Stephen Matthew Hatfield · Northeastern University · R01 · FY2023 · EB

NCTN Deep South Research Consortium

$450,954
Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2025 · CA

Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer

$450,927
Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2011 · CA

Single-cell (phospho-)proteomics platform for functional analysis of tumor microenvironment

$450,904
Tujin Shi · Battelle Pacific Northwest Laboratories · R33 · FY2025 · CA

Structure and Mechanism of HECT E3 Ubiquitin Ligases

$450,900
Donald Eric Spratt · Clark University (Worcester, Ma) · R15 · FY2017 · GM

Discrete Frequency Infrared Spectroscopic Imaging for Breast Histopathology

$450,890
Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2025 · EB

PROMINENT - IARC

$450,879
Paul Joseph Brennan · International Agency For Res On Cancer · OT2 · FY2023 · CA

Health Outcomes and Dioxin Exposure of Women and Children in Seveso

$450,806
Brenda Eskenazi · University Of California Berkeley · R01 · FY2008 · ES

Stanford Breast Metastasis Center Administrative Core

$450,805
Christina N Curtis · Stanford University · U54 · FY2024 · CA

Development of Virtual Tumor

$450,782
Massachusetts General Hospital · U56 · FY2004 · CA